Microreactor

Information

  • Patent Grant
  • 7485454
  • Patent Number
    7,485,454
  • Date Filed
    Tuesday, November 7, 2000
    23 years ago
  • Date Issued
    Tuesday, February 3, 2009
    15 years ago
Abstract
Chemical and biological reactors, including microreactors, are provided. Exemplary reactors include a plurality of reactors operable in parallel, where each reactor has a small volume and, together, the reactors produce a large volume of product. Reaction systems can include mixing chambers, heating/dispersion units, reaction chambers, and separation units. Components of the reactors can be readily formed from a variety of materials. For example, they can be etched from silicon. Components are connectable to and separable from each other to form a variety of types of reactors, and the reactors can be attachable to and separable from each other to add significant flexibility in parallel and/or series reactor operation.
Description
FIELD OF THE INVENTION

The present invention relates generally to chemical or biochemical microreactors, and more particularly to a microreactor for the production of the product of a chemical or biochemical reaction, including a plurality of individuated microreactors constructed to operate in parallel.


BACKGROUND OF THE INVENTION

A wide variety of reaction systems are known for the production of the product of chemical or biochemical reactions. Chemical plants involving catalysis, biochemical fermenters, pharmaceutical production plants, and a host of other systems are well-known.


Systems for housing chemical and biochemical reactions not necessarily for the production of product also are known. For example, continuous-flow systems for the detection of various analytes in bodily fluids including blood, such as oxygen, glucose, and the like are well known.


In many of these and other systems, the capacity of the system (the volume of material that the system is designed to produce, process, or analyze) is adjusted in accordance with the volume of reactant, product, or analyte desirably processed or analyzed. For example, in large-scale chemical or pharmaceutical production, reactors are generally made as large as possible to generate as large a volume of product as possible. Conversely, in many areas of clinical diagnosis, where it is desirable to obtain as much information as possible from as small a physiological sample as possible (e.g., from a tiny drop of blood), it is a goal to minimize the size of reaction chambers of sensors. Several examples of small-scale reactor systems, including those used in clinical diagnoses and other applications, follow.


U.S. Pat. No. 5,387,329 (Foos, et al.; Feb. 7, 1995) describes an extended use planar clinical sensor for sensing oxygen levels in a blood sample.


U.S. Pat. No. 5,985,119 (Zanzucchi, et al.; Nov. 16, 1999) describes small reaction cells for performing synthetic processes in a liquid distribution system. A variety of chemical reactions including catabolic, anabolic reactions, oxidation, reduction, DNA synthesis, etc. are described.


U.S. Pat. No. 5,674,742 (Northrup, et al.; Oct. 7, 1997) describes an integrated microfabricated instrument for manipulation, reaction, and detection of microliter to picoliter samples. The system purported by is suitable for biochemical reactions, particularly DNA-based reactions such as the polymerase chain reaction.


U.S. Pat. No. 5,993,750 (Ghosh, et al.; Nov. 30, 1999) describes an integrated micro-ceramic chemical plant having a unitary ceramic body formed from multiple ceramic layers in the green state which are sintered together defining a mixing chamber, passages for delivering and reacting fluids, and means for delivering mixed chemicals to exit from the device.


Biochemical processing typically involve the use of a live microorganism (cells) to produce a substance of interest. Biochemical and biomedical processing account for about 50% of the total drug, protein and raw amino-acid production worldwide. Approximately 90% of the research and development (R&D) budget in pharmaceutical industries is currently spent in biotechnology areas.


Currently bioreactors (fermentors) have several significant operational limitations. The most important being maximum reactor size which is linked to aeration properties, to nutrient distribution, and to heat transfer properties. During the progression of fermentation, the growth rate for cells accelerates, and the measures required to supply the necessary nutrients and oxygen sets physical and mechanical constraints on the vessel within which the cells are contained. Powerful and costly drives are needed to compensate for inefficient mixing and low mass-transfer rates. Additionally, as metabolism of cells accelerates, the cells generate increased heat which needs to be dissipated from the broth.


The heat transfer characteristics of the broth and the vessel (including heat exchanger) impose serious constraints on the reaction scale possible (see Table 1). While the particular heat load and power requirements are specific to the reaction, the scale of reaction generally approaches limitations as ˜10 m3 as in the case of E. coli fermentation (Table 1). The amount of heat to be dissipated becomes excessive due to limits on heat transfer coefficients of the broth and vessel. Consequently, the system of vessel and broth will rise in temperature. Unfortunately, biological compounds often have a relatively low upper limit on temperature for which to survive (<45° C. for many). Additionally, power consumption to disperse nutrients and oxygen and coolant requirements to control temperature make the process economically unfeasible (see Table 1).









TABLE 1







Oxygen- and Heat- Transfer Requirements for E. coli: Effects of Scale












OTR
Volumea
Pressure
Power
Heat Load
Coolantb


(mmol/L · h)
(m3)
(psig)
(hp)
(Btu/h)
(° F.)















150
1
15
5.0
84000
40


200
1
25
4.9
107000
40


300
1
35
7.1
161000
40


400
1
35
6.9
208000
40


150
10
15
50.2
884000
40


200
10
25
50.0
1078000
40


300
10
35
75.7
1621000
22


400
10
35
77.0
2096000
5






aLiquid volume




bCoolant flow is 35 gal/mm for 1-m3 vessel and 100 gal/mm for 10-m3 vessel




cCharles, M. and Wilson, J. Fermentor Design; In: Bioprocess Engineering; Lydersen, B. K., D′Elia, N. A., Nelson, K. L., Ed.; John Wiley & Sons, Inc., New York, 1994.







Aside from reactor scalability, the design of conventional fermentors has other drawbacks. Due to the batch and semi-batch nature of the process, product throughput is low. Also, the complexity and coupled nature of the reaction parameters, as well as the requirement of narrow ranges for these parameters, makes control of the system difficult. Internal to the system, heterogeneity in nutrient and oxygen distribution due to mixing dynamics creates pockets in the broth characterized by insufficient nutrients or oxygen resulting in cell death. Finally, agitation used to produce as homogeneous a solution as possible (typically involving impellar string to simultaneously mix both cells and feeds of oxygen and nutrients) causes high strains which can fracture cell membranes and cause denaturation.


While a wide variety of useful reactors for a variety of chemical and biological reactions, on a variety of size scales exist, a need exists in the art for improved reactors. In particular, there is a current need to significantly improve the design of bioreactors especially as the pharmaceutical and biomedical industries shift increasingly towards bioprocessing.


SUMMARY OF THE INVENTION

The present invention provides systems, methods, and reactors associated with small-scale chemical or biochemical reactions.


In one aspect the invention provides a chemical or biochemical reactor. The reactor includes a reaction unit including a chamber having a volume of less than one milliliter. The chamber includes an inlet connectable to a source of a chemical or biological starting material and an outlet for release of a product of a chemical or biological reaction involving the starting material. A collection chamber is connectable to the outlet of the reaction chamber. The collection chamber has a volume of greater than one liter.


In another aspect the invention involves a chemical or biochemical reactor system. The system includes a mixing chamber including a plurality of inlets connectable to a plurality of sources of chemical or biochemical reagents, and an outlet. A reaction chamber is connectable to and removable from the mixing chamber, and has a volume of less than one milliliter. The reaction chamber includes an inlet connectable to and removable from the outlet of the mixing chamber, and an outlet for release of a product of a chemical or biological reaction involving the starting material.


In another aspect the invention provides methods. One method includes carrying out a chemical or biological reaction in a plurality of reaction chambers operable in parallel, where each reaction chamber has a volume of less than one milliliter. Product of the reaction is discharged from the plurality of reaction chambers simultaneously into a collection chamber having a volume of greater than one liter.


Other advantages, novel features, and objects of the invention will become apparent from the following detailed description of the invention when considered in conjunction with the accompanying drawings, which are schematic and which are not intended to be drawn to scale. In the figures, each identical or nearly identical component that is illustrated in various figures is represented by a single numeral. For purposes of clarity, not every component is labeled in every figure, nor is every component of each embodiment of the invention shown where illustration is not necessary to allow those of ordinary skill in the art to understand the invention.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates a microbioreactor of the invention including mixing, heating/dispersion, reaction, and separation units, in expanded view;



FIG. 1A illustrates a microbioreactor of the invention including various mixing, heating/dispersion, reaction, and separation units, in expanded view;



FIG. 2 illustrates the system of FIG. 1 as assembled;



FIG. 3 illustrates the mixing unit of the system of FIG. 1;



FIG. 4 is an expanded view of the heating/dispersion unit of the system of FIG. 1;



FIG. 5 is an expanded view of the reaction chamber of the system of FIG. 1; and



FIG. 6 is an expanded view of the separation unit of the system of FIG. 1.





DETAILED DESCRIPTION OF THE INVENTION

The present invention provides a chemical or biochemical reactor that can be used for a variety of very small-scale techniques. In one embodiment, a microreactor of the invention comprises a matrix of a few millimeters to a few centimeters in size containing reaction channels with dimensions on the order of hundreds of microns. Reagents of interest are allowed to flow through these microchannels, mixed, and reacted together. The products can be recovered, separated, and treated within the system. While one microreactor may be able only to hold and react a few microliters of the substances of interest, the technology allows for easy scalability and tremendous parallelization. With enhanced oxygen and nutrient distribution, a microreactor of the invention demonstrates increased performance in terms of cell viability. The microreactor geometry resembles closely the natural environment of cells whereby diffusional oxygen and nutrient transfer take place through a high surface area, thin layer interface.


With regard to throughput, an array of many microreactors can be built in parallel to generate capacity on a level exceeding that allowed by current vessels and more uniform in product quality than can be obtained in a batch method. Additionally, an advantage is obtained by maintaining production capacity at the scale of reactions typically performed in the laboratory. In general, the coupled parameters for heat and mass transfer that are determined on the lab-scale for a process do not scale linearly with volume. With conventional reactors, as the magnitude of volume is increased 1,000-1,000,000 times for production, these parameters need to be re-evaluated, often involving a large capital-investment. The use of small production volumes, although scaled in parallel, reduces the cost of current scale-up schemes.


Furthermore, the process can be implemented on a simple platform, such as an etched article for example, a silicon wafer. With the effort of semiconductor manufacturing being towards the reduction in the dimensions of channels, an opportunity to utilize excess capacity within these production facilities (with unused equipment for the larger dimensions) is provided. Mass production of these units can be carried out at very low cost and an array of many reactors, for example thousands of microreactors typically can be built for a price lower than one traditional bioreactor.


Referring now to FIG. 1, a chemical or biochemical reactor in accordance with one embodiment of the invention is illustrated schematically. The reactor of FIG. 1 is, specifically, a microbioreactor for cell cultivation. It is to be understood that this is shown by way of example only, and the invention is not to be limited to this embodiment. For example, systems of the invention can be adapted for pharmaceutical production, hazardous chemical production, or chemical remediation of warfare reagents, etc.


Microreactor 10 includes four general units. A mixing unit 12, a heating/dispersion unit 14, a reaction unit 16, and a separation unit 18. That is, in the embodiment illustrated, processes of mixing, heating, reaction, purification are implemented in series. Although not shown, pressure, temperature, pH, and oxygen sensors can be included, for example embedded within the network to monitor and provide control for the system. Due to the series format, the opportunity for several reaction units in series for multi-step chemical syntheses, for several levels of increased purification, or for micro-analysis units is provided as well.



FIG. 1 shows microreactor 10 in expanded view. As illustrated, each of units 14 and 16 (heating/dispersion and reaction units, respectively) includes at least one adjacent temperature control element 20-26 including a channel 28 through which a temperature-control fluid can be made to flow. As illustrated, temperature control units 20 and 24 are positioned above and below unit 14 and units 22 and 26 are positioned above and below unit 16. Separation unit 18 includes upper and lower extraction solvent fluid units 30 and 32, respectively, separated from unit 18 by membranes 34 and 36, respectively. FIG. 1A shows a similar microreactor having more than one reaction unit (certain elements removed for purposes of clarity).


Referring now to FIG. 2, reactor 10 is illustrated as assembled. The individual units of microreactor 10 will now be described in greater detail.


Referring now to FIG. 3, mixing unit 12 is illustrated. Mixing unit 12 is designed to provide a homogeneous mixture of starting materials or reactants to be provided to the reaction units, optionally via the heating/dispersion unit. In the specific example of the microbioreactor, mixing unit 12 is designed to provide a homogeneous broth with sufficient nutrients and oxygen, and at the required pH, for cells. Rather than combine the mixing process with simultaneous nourishment of the cells, the process is performed in a preliminary stage and then fed to the reaction stage where cells are immobilized. In this manner, the cells do not experience any shear stress due to mixing and a homogeneous mixture of feed requirements is guaranteed.


As is the case for other components of the reactor, mixing unit 12 can be manufactured using any convenient process. In preferred embodiments the unit is etched into a substrate such as silicon via known processes such as lithography. Other materials from which mixing unit 12, or other components of the systems of the invention can be fabricated, include glass, fused silica, quartz, ceramics, or suitable plastics. Silicon is preferred. The mixing unit includes a plurality of inlets 40-50 which can receive any of a variety of reactants and/or fluid carriers. Although six inlets are illustrated, essentially any number of inlets from one to tens of hundreds of inlets can be provided. Typically, less than ten inlets are needed for a given reaction. Mixing unit 12 includes an outlet 52 and, between the plurality of inlets and the outlet, a mixing chamber 54 constructed and arranged to coalesce a plurality of reactant fluids provided through the inlets. It is a feature of the embodiment illustrated that the mixing chamber is free of active mixing elements. Instead, the mixing chamber is constructed to cause turbulence in the fluids provided through the inlets thereby mixing and delivering a mixture of the fluids through the outlet without active mixing. Specifically, the mixing unit includes a plurality of obstructions 56 in the flow path that causes mixture of fluid flowing through the flow path. These obstructions can be of essentially any geometrical arrangement. As illustrated, they define small pillars about which the fluid must turbulently flow as it passes from the inlets through the mixing chamber toward the outlet. As used herein “active mixing elements” is meant to define mixing elements such as blades, stirrers, or the like which are movable relative to the reaction chamber itself, that is, movable relative to the walls defining the reaction chamber.


The volume of the mixing chamber, that is, the volume of the interior of mixing unit 12 between the inlets and the outlet, can be very small in preferred embodiments. Specifically, the mixing chamber generally has a volume of less than one liter, preferably less than about 100 microliters, and in some embodiments less than about 10 microliters. The chamber can have a volume of less than about five microliters, or even less than about one microliter.


Specifically, in the microbioreactor illustrated, six separate feed streams empty into the mixing chamber under pressure. One feed stream provides gaseous oxygen (O2) as a cell requirement. One stream, respectively, provides carbon dioxide (CO2) and nitrogen (N2) for altering pH. The remaining three channels provide the broth solution including solvent and nutrients. One of these latter streams can also be utilized to provide any additional requirements for the system such as antifoaming agents. Antifoaming agents are sometimes necessary to prevent production of foam and bubbles that can damage cells within the broth. The feed of the various streams into the chamber provides enough turbulence for mixing of the different streams. Flow within microfluidic devices is characterized by a low Reynolds number indicating the formation of lamina. While the turbulence created by the injection streams should provide sufficient mixing before the development of laminar flow, pilon-like obstructions 56 are placed in the flow path of the stream leaving the primary mixing chamber in order to enhance mixing of the lamina. By splitting a main stream into substreams followed by reunification, turbulence is introduced in the flow path, and a mechanism other than simple diffusion is used to facilitate further mixing. The length of this mixing field can be lengthened or shortened depending on the system requirements.


Referring now to FIG. 4, heating/dispersion unit 14 is shown. Unit 14 can be formed as described above with respect to other units of the invention. Unit 14 includes an inlet 60 in fluid communication with a plurality of outlets 62 in embodiments where dispersion as described below is desirable. In operation, a stream of homogeneous fluid exiting the mixing unit (feed broth in the specific microbioreactor embodiment shown) enters a dispersion matrix defined by a plurality of obstruction dividing the stream into separate flow paths directed toward the separate outlets 62. The dispersion matrix is sandwiched between two temperature control elements 20 and 24 which, as illustrated, include fluid flow channels 28 etched in a silicon article. Control unit 24 is positioned underneath unit 14, thus etched channel 28 is sealed by the bottom of unit 14. Control unit 20 is positioned atop unit 14 such that the bottom of unit 20 seals and defines the top of diffusion unit 14. A cover (not shown) can be placed a top unit 20 to seal channel 28.


Rather than for mixing, as in the previous case (FIG. 3), the splitting of the streams is to disperse the medium for its entrance into the reactive chamber in the next unit operation. In traditional reactor systems, fluid flow about a packing material containing catalysts produces the desired reaction. However, if the fluid is not evenly dispersed entering the chamber, the fluid will flow through a low resistance path through the reactor and full, active surface area will not be utilized. Dispersion in this case is to optimize reactor efficiency in the next stage.


With regard to the heating function of this unit, the platform functions as a miniaturized, traditional heat exchanger. Etched silicon platforms both above and below the central platform serve to carry a heated fluid. Cells typically require their environment to have a temperature of ˜30° C. The fluids flowing in the etched coils both above and below the broth flow channel heating the broth through the thin silicon layer. The temperature of the fluid in the upper and lower heat exchangers can be modified to ensure proper temperature for the broth. Additionally, the platform can be extended for increased heating loads.


Although a combination heating/dispersion unit is shown, unit 14 can be either a dispersion unit or a heating unit. For example, dispersion can be provided as shown, without any temperature control. Alternatively, no dispersion need be provided (inlet 60 can communicate with a single outlet 62, which can be larger than the outlets as illustrated) and heating units can be provided. Cooling units can be provided as well, where cooling is desired. Units 20 and 24 can carry any temperature-control fluid, whether to heat or cool.


Referring now to FIG. 5, reaction chamber 16 is shown, including temperature control units 22 and 26, in expanded form. Units 22 and 26 can be the same as units 20 and 24 as shown in FIG. 4, with unit 22 defining the top of reaction chamber 16. Reaction unit 16 includes an inlet 70 fluidly communicating with an outlet 72 and a reaction chamber defined therebetween. The reaction chamber, in microreactor embodiments of the invention, has a volume of less than one milliliter, or other lower volumes as described above in connection with mixing unit 12. Inlet 70 is connectable to a source of a chemical or biological starting material, optionally supplied by mixing unit 12 and heating/dispersion unit 14, and outlet 70 is designed to release the product of a chemical or biological reaction occurring within the chamber involving the starting material. Unit 16 can be formed from materials as described above.


The reactor unit is the core of the process. While the unit is designed to be interchangeable for biological or pharmaceutical reactions, the specific application as shown is for cell cultivation. As in the case of the previous unit, temperature control units such as heat exchanger platforms will sandwich the central reaction chamber. The heat exchangers will maintain the temperature of the reaction unit as the same temperature as discussed for the cell broth.


A feature of the unit is heterogeneous reaction on a supported matrix. Cell feed enters the reaction chamber under the proper pH, O2 concentration, and temperature for cell cultivation. Cells, immobilized onto the silicon framework at locations 74 either by surface functionalization and subsequent reaction or entrapment within a host membrane, metabolize the nutrients provided by the feed stream and produce a product protein. The initial reaction platform can be a two-dimensional array of cells both on the top and bottom of the reaction chamber. This arrangement is to prevent a large pressure drop across the unit which would be detrimental to flow.


In this unit, oxygen and nutrients are diffused from the flowing stream to the immobilized cells. The cells, in turn metabolize the feed, and produce proteins which are swept away in the flowing stream. The flowing stream then enters the fourth chamber which removes the protein product from the solution.


Referring again to FIG. 1, it can be seen how dispersion unit 14 creates an evenly-divided flow of fluid (reactant fluid such as oxygen and nutrients in the case of cell cultivation) across each of locations 74 in reaction to chamber 16.


Referring now to FIG. 6, separation unit 18 is shown in greater detail, in expanded view. Separation unit 18 defines a central unit including an inlet 80 communicating with an outlet 82, and a fluid pathway 84 connecting the inlet with the outlet. Unit 18 can be fabricated as described above with respect to other components of the invention, and preferably is etched silicon. It may be desirable for fluid path 84 to completely span the thickness of unit 18 such that the pathway is exposed both above and below the unit. To maintain structural integrity, pathway 84 can be etched to some extent but not completely through unit 18 as illustrated, and a plurality of holes or channels can be formed through the bottom of the pathway exposing the bottom of the pathway to areas below the unit. Inlet 80 can be connectable to the outlet of reaction chamber 16, and outlet 82 to a container for recovery of carrier fluid.


In the embodiment illustrated, membranes 34 and 36 cover exposed portions of fluid pathway 84 facing upward or downward as illustrated. Membranes 34 and/or 36 can be any membranes suitable for separation, i.e. extraction of product through the membrane with passage of effluent, or carrier fluid, through outlet 82. Those of ordinary skill in the art will recognize a wide variety of suitable membranes including size-selective membranes, ionic membranes, and the like. Upper and lower extraction solvent fluid units 30 and 32, which can comprise materials as described above including etched silicon, each include a fluid pathway 86 connecting an inlet 88 with an outlet 90. Fluid pathway 86 preferably is positioned in register with fluid pathway 84 of unit 18 when the separation unit is assembled. In this way, two flowing streams of solvent through channels 86 of units 30 and 32 flow counter to the direction of flow of fluid in channel 84 of unit 18, the fluids separated only by membranes 34 and 36. This establishes a counter-current tangential flow filtration membrane system. By concentration gradients, products are selectively extracted from channel 84 into solvent streams flowing within channels 86 and unit 30 or 32. Product is recovered through the outlet 90 of units 30 or 32 and recovered in a container (not shown) having a volume that can be greater than 1 liter. Outlets 90 thereby define carrier fluid outlets, and a fluid pathway connects inlet 80 of unit 18 with the carrier fluid outlets 90 of units 30 and 32, breached only by membranes 34 and 36. Carrier fluid outlet 82 can be made connectable to a recovery container for recycling of reaction carrier fluids. In the example of a microbioreactor, residual oxygen and nutrients are recovered from outlet 82 and recycled back into the feed for the process.


The flowing streams of extraction solvent in channels 86 can be set at any desired temperature using temperature control units (not illustrated). In the case of a microbioreactor, these fluids can be set at approximately 4° C. The low temperature is needed to maintain the efficacy of the protein products and prevent denaturation. Additionally, several purification and clarification steps are often performed in industrial application. The necessity of further purification is remedied by the use of additional units in series.


Embedded within the production process can be control systems and detectors for the manipulation of temperature, pH, nutrients, and oxygen concentration. Where a microbiorector is used, the viability of cells is dependent upon strict limits for the parameters mentioned above. Narrow set-point ranges, dependent on the cell system selected, can be maintained using thermocouples, pH detectors, O2 solubility detectors, and glucose detectors between each unit. These measurements will determine the heat exchanger requirements, O2, CO2, N2, and nutrient inputs.


Diaphragm and peristaltic pumps can be used to provide the necessary driving force for fluid flow in the units. Such pumps are also used to maintain flow in the heat exchanger units.


It is a feature of the invention that many of the microreactors as illustrated can be arranged in parallel. Specifically, at least ten reactors can be constructed to operate in parallel, or in other cases at least about 100, 500, 1,000, or even 10,000 reactors can be constructed to operate in parallel. These reactors can be assembled and disassembled as desired.


It is another feature of the invention that individual units 12, 14, 16, and 18 can be constructed and arranged to be connectable to and separable from each other. That is, any arrangement of individual components can be created for a desired reaction. For example, with reference to FIG. 1, heating/dispersion unit 14 may not be necessary. That is, outlet 52 of mixing unit 12 can be connectable to either inlet 60 of heating/dispersion unit 14, or inlet 70 of reaction unit 16 where a heating/dispersion unit is not used. Moreover, assembly and disassembly of reactors to create a system including many, many reactors operating in parallel, as described above, or in series is possible because of the connectability and separability of the components from each other to form systems containing specific desired components, and any number of those or other systems operating together. Equipment for connection and separation of individual components of a reactor can be selected among those known in the art, as can systems for connection of a variety of reactors in parallel or in series. Systems should be selected such that the individual components can be connectable to and separable from each other readily by laboratory or production-facility technicians without irreversible destruction of components such as welding, sawing, or the like. Examples of known systems for making readily reversible connections between components of reactors or between reactors to form parallel reactors or series reactors include male/female interconnections, clips, cartridge housings where components comprise inserts within the housings, screws, or the like.


Those skilled in the art would readily appreciate that all parameters listed herein are meant to be exemplary and that actual parameters will depend upon the specific application for which the methods and apparatus of the present invention are used. It is, therefore, to be understood that the foregoing embodiments are presented by way of example only and that, within the scope of the appended claims and equivalents thereto, the invention may be practiced otherwise than as specifically described. In the claims the words “including”, “carrying”, “having”, and the like mean, as “comprising”, including but not limited to.

Claims
  • 1. A system for maintaining and cultivating cells in culture and obtaining a protein resulting from interaction of the cells with oxygen and/or nutrients and/or other components, comprising: a small-scale chemical or biochemical reactor comprising a plastic substrate comprising at least one reaction unit, the reactor comprising an inlet, an outlet, and a fluid pathway connecting the inlet and the outlet, the fluid pathway comprising a chamber having a surface suitable for cell growth and a volume of less than about 1 ml, the chamber being constructed and arranged to maintain and cultivate cells in culture, the chamber further comprising an inlet fluidly connectable to a source of nutrients for the cells having a controlled pH, and an outlet for release of the protein resulting from the interaction involving the cells in the chamber;a membrane defining at least one wall of the fluid pathway;an enclosure positioned proximate the membrane, wherein at least one product of the interaction involving cells in the chamber passes across the membrane into the enclosure;the reactor further comprising a pH sensor.
  • 2. A system for maintaining and cultivating cells in culture and obtaining a protein resulting from interaction of the cells with oxygen and/or nutrients and/or other components, comprising: a small-scale chemical or biochemical reactor comprising a plastic substrate comprising at least one reaction unit, the reactor comprising an inlet, an outlet, and a fluid pathway connecting the inlet and the outlet, the fluid pathway comprising a chamber having a surface suitable for cell growth and a volume of less than about 1 ml, the chamber being constructed and arranged to maintain and cultivate cells in culture, the chamber further comprising an inlet fluidly connectable to a source of nutrients for the cells having a controlled pH, and an outlet for release of the protein resulting from the interaction involving the cells in the chamber;a membrane defining at least one wall of the fluid pathway;an enclosure positioned proximate the membrane, wherein at least one product of the interaction involving cells in the chamber passes across the membrane into the enclosure;the reactor further comprising an oxygen sensor.
  • 3. A system as in claim 1, further comprising means for controlling the temperature of the chamber to maintain a temperature suitable for cultivating cells to generate the protein resulting from interaction of the cells with oxygen and/or nutrients and/or other components.
  • 4. A system as in claim 1, further comprising a mixing unit fluidly connectable to the inlet of the chamber, the mixing unit including an outlet connectable to the inlet of the chamber, a plurality of inlets each in fluid communication with the outlet and a mixing chamber between plurality of inlets and of the outlet.
  • 5. A system as in claim 4, wherein the mixing chamber is free of active mixing elements.
  • 6. A system as in claim 2, wherein the system comprises a plurality of reaction units attachable to and separable from each other, the plurality of reaction units being constructed and arranged to operate in parallel.
RELATED APPLICATION

This application claims the benefit of priority under 35 U.S.C. §119(e) of co-pending U.S. Provisional Patent Application Ser. No. 60/188,275, filed Mar. 10, 2000.

US Referenced Citations (259)
Number Name Date Kind
4038151 Fadler et al. Jul 1977 A
4116775 Charles et al. Sep 1978 A
4118280 Charles et al. Oct 1978 A
4318994 Meyer et al. Mar 1982 A
4720462 Rosenson Jan 1988 A
4756884 Hillman et al. Jul 1988 A
4839292 Cremonese Jun 1989 A
4952373 Sugarman et al. Aug 1990 A
5004685 Arai et al. Apr 1991 A
5047213 Finlan et al. Sep 1991 A
5051237 Grenner et al. Sep 1991 A
5173225 Range et al. Dec 1992 A
5219762 Katamine et al. Jun 1993 A
5252294 Kroy et al. Oct 1993 A
5254143 Anazawa et al. Oct 1993 A
5278048 Parce et al. Jan 1994 A
5387329 Foos et al. Feb 1995 A
5424209 Kearney Jun 1995 A
5430542 Shepherd Jul 1995 A
5436129 Stapleton Jul 1995 A
5449617 Falkenberg et al. Sep 1995 A
5478751 Oosta et al. Dec 1995 A
5496697 Parce et al. Mar 1996 A
5534328 Ashmead et al. Jul 1996 A
5576211 Falkenberg et al. Nov 1996 A
5580523 Bard Dec 1996 A
5587128 Wilding et al. Dec 1996 A
5589350 Bochner Dec 1996 A
5593632 Kagawa Jan 1997 A
5595712 Harbster et al. Jan 1997 A
5602028 Minchinton Feb 1997 A
5612188 Shuler et al. Mar 1997 A
5632957 Heller et al. May 1997 A
5639423 Northrup Jun 1997 A
5646039 Northrup Jul 1997 A
5674742 Northrup et al. Oct 1997 A
5705018 Hartley Jan 1998 A
5744366 Kricka et al. Apr 1998 A
5800785 Bochner Sep 1998 A
5800788 Douren Sep 1998 A
5840258 Hyppanen Nov 1998 A
5842787 Kopf-Sill et al. Dec 1998 A
5846396 Zanzucchi et al. Dec 1998 A
5856174 Lipshutz Jan 1999 A
5858770 Perlman Jan 1999 A
5916812 Chen et al. Jun 1999 A
5928880 Wilding et al. Jul 1999 A
5942443 Parce et al. Aug 1999 A
5957579 Kopf-Sill et al. Sep 1999 A
5958694 Nikiforov Sep 1999 A
5964995 Nikiforov et al. Oct 1999 A
5965092 Chatterjee et al. Oct 1999 A
5972187 Parce et al. Oct 1999 A
5976472 Chatterjee et al. Nov 1999 A
5981211 Hu et al. Nov 1999 A
5985119 Zanzucchi et al. Nov 1999 A
5989835 Dunlay et al. Nov 1999 A
5992769 Wise et al. Nov 1999 A
5993750 Ghosh et al. Nov 1999 A
6001352 Boyan et al. Dec 1999 A
6001585 Gramer Dec 1999 A
6008010 Greenberger et al. Dec 1999 A
6012902 Parce Jan 2000 A
6025601 Trulson et al. Feb 2000 A
6042710 Dubrow Mar 2000 A
6043080 Lipshutz et al. Mar 2000 A
6046056 Parce et al. Apr 2000 A
6090251 Sundberg et al. Jul 2000 A
6103199 Bjornson et al. Aug 2000 A
6103479 Taylor Aug 2000 A
6107044 Nikiforov Aug 2000 A
6117643 Simpson et al. Sep 2000 A
6126946 Counsell et al. Oct 2000 A
6143247 Sheppard, Jr. et al. Nov 2000 A
6148968 Davison Nov 2000 A
6150180 Parce et al. Nov 2000 A
6167910 Chow Jan 2001 B1
6171067 Parce Jan 2001 B1
6171850 Nagle et al. Jan 2001 B1
6174675 Chow et al. Jan 2001 B1
6176962 Soane et al. Jan 2001 B1
6184029 Wilding et al. Feb 2001 B1
6186660 Kopf-Sill et al. Feb 2001 B1
6193647 Beebe et al. Feb 2001 B1
6221226 Kopf-Sill Apr 2001 B1
6221654 Quake et al. Apr 2001 B1
6235175 Dubrow et al. May 2001 B1
6238538 Parce et al. May 2001 B1
6245295 Chen et al. Jun 2001 B1
6251343 Dubrow et al. Jun 2001 B1
6264892 Kaltenbach et al. Jul 2001 B1
6267858 Parce et al. Jul 2001 B1
6274089 Chow et al. Aug 2001 B1
6274337 Parce et al. Aug 2001 B1
6319469 Mian et al. Nov 2001 B1
6319474 Krulevitch et al. Nov 2001 B1
6321791 Chow Nov 2001 B1
6338790 Feldman et al. Jan 2002 B1
6339023 Kitazaki et al. Jan 2002 B1
6346413 Fodor et al. Feb 2002 B1
6368871 Christel et al. Apr 2002 B1
6377721 Walt et al. Apr 2002 B1
6387651 Bochner et al. May 2002 B1
6410309 Barbera-Guillem et al. Jun 2002 B1
6440722 Knapp et al. Aug 2002 B1
6455310 Barbera-Guillem Sep 2002 B1
6461812 Barth et al. Oct 2002 B2
6461861 Schilling et al. Oct 2002 B2
6479252 Barbera-Guillem et al. Nov 2002 B1
6479299 Parce et al. Nov 2002 B1
6488895 Kennedy Dec 2002 B1
6488897 Dubrow et al. Dec 2002 B2
6494230 Chow Dec 2002 B2
6494614 Bennett et al. Dec 2002 B1
6509085 Kennedy Jan 2003 B1
6517234 Kopf-Sill et al. Feb 2003 B1
6534013 Kennedy Mar 2003 B1
6537799 Chow et al. Mar 2003 B2
6542863 Surucu Apr 2003 B1
6547941 Kopf-Sill et al. Apr 2003 B2
6551841 Wilding et al. Apr 2003 B1
6552784 Dietz et al. Apr 2003 B1
6555067 Gandhi et al. Apr 2003 B1
6555365 Barbera-Guillem et al. Apr 2003 B2
6558944 Parce et al. May 2003 B1
6569674 McGarry May 2003 B1
6582576 Chow et al. Jun 2003 B1
6592733 Foley et al. Jul 2003 B1
6592821 Wada et al. Jul 2003 B1
6597438 Cabuz et al. Jul 2003 B1
6599436 Matzke et al. Jul 2003 B1
6602714 Tagge et al. Aug 2003 B1
6613581 Wada et al. Sep 2003 B1
6614030 Maher et al. Sep 2003 B2
6632656 Thomas et al. Oct 2003 B1
6642046 McGarry et al. Nov 2003 B1
6645432 Anderson et al. Nov 2003 B1
6648015 Chow Nov 2003 B1
6653124 Freeman Nov 2003 B1
6699665 Kim et al. Mar 2004 B1
6716588 Sammak et al. Apr 2004 B2
6716620 Bashir et al. Apr 2004 B2
6716629 Hess et al. Apr 2004 B2
6734436 Faris et al. May 2004 B2
6742661 Schulte et al. Jun 2004 B1
6743633 Hunter Jun 2004 B1
6756019 Dubrow et al. Jun 2004 B1
6761962 Bentsen et al. Jul 2004 B2
6770434 Shvets et al. Aug 2004 B2
6790652 Terry et al. Sep 2004 B1
6806543 Yamakawa et al. Oct 2004 B2
6811752 Barbera-Guillem Nov 2004 B2
6818436 Yamamoto et al. Nov 2004 B2
6821772 Barbera-Guillem et al. Nov 2004 B2
6827095 O'Connor et al. Dec 2004 B2
6837926 David Jan 2005 B2
6837927 David Jan 2005 B2
6848462 Covington et al. Feb 2005 B2
6849463 Santini, Jr. et al. Feb 2005 B2
6857449 Chow Feb 2005 B1
6884580 Caren et al. Apr 2005 B2
6919046 O'Connor et al. Jul 2005 B2
6937330 Dietz et al. Aug 2005 B2
6949377 Ho Sep 2005 B2
6981522 O'Connor et al. Jan 2006 B2
6994749 David Feb 2006 B2
7005292 Wilding et al. Feb 2006 B2
7026124 Barth et al. Apr 2006 B2
7028536 Karp et al. Apr 2006 B2
7033474 Dubrow et al. Apr 2006 B1
7033819 Kim et al. Apr 2006 B2
7033821 Kim et al. Apr 2006 B2
7052880 McEntee May 2006 B2
20010024821 Potter Sep 2001 A1
20020029814 Unger et al. Mar 2002 A1
20020055166 Cannon May 2002 A1
20020068358 Campbell et al. Jun 2002 A1
20020069619 Abasolo et al. Jun 2002 A1
20020069620 Abasolo Jun 2002 A1
20020072113 Barbera-Guillem et al. Jun 2002 A1
20020072116 Bhatia et al. Jun 2002 A1
20020086439 Nagle et al. Jul 2002 A1
20020092767 Bjornson et al. Jul 2002 A1
20020097633 O'Connor et al. Jul 2002 A1
20020100714 Staats Aug 2002 A1
20020110905 Barbera-Guillem et al. Aug 2002 A1
20020117517 Unger et al. Aug 2002 A1
20020146817 Cannon et al. Oct 2002 A1
20020168757 Kirk et al. Nov 2002 A1
20020172621 Barbera-Guillem Nov 2002 A1
20020176804 Strand et al. Nov 2002 A1
20020177159 Bedilion et al. Nov 2002 A1
20020182749 Singh et al. Dec 2002 A1
20020185183 O'Connor et al. Dec 2002 A1
20020185431 Karp Dec 2002 A1
20020187074 O'Connor et al. Dec 2002 A1
20020187560 Pezzuto et al. Dec 2002 A1
20020197603 Chow et al. Dec 2002 A1
20030005877 David Jan 2003 A1
20030008308 Enzelberger et al. Jan 2003 A1
20030008388 Barbera-Guillem et al. Jan 2003 A1
20030013203 Jedrzejewski et al. Jan 2003 A1
20030015429 Dubrow et al. Jan 2003 A1
20030022153 Kirk et al. Jan 2003 A1
20030022197 Kirk et al. Jan 2003 A1
20030022203 Kumar Jan 2003 A1
20030022269 Kirk et al. Jan 2003 A1
20030022362 Kirk et al. Jan 2003 A1
20030026740 Staats Feb 2003 A1
20030040104 Barbera-Guillem Feb 2003 A1
20030049862 He et al. Mar 2003 A1
20030077817 Zarur et al. Apr 2003 A1
20030082632 Shumate May 2003 A1
20030082795 Shuler et al. May 2003 A1
20030091476 Zhou et al. May 2003 A1
20030104512 Freeman et al. Jun 2003 A1
20030129646 Briscoe et al. Jul 2003 A1
20030129665 Selvan et al. Jul 2003 A1
20030134431 Parce et al. Jul 2003 A1
20030138819 Gong et al. Jul 2003 A1
20030138829 Unger et al. Jul 2003 A1
20030142291 Padmanabhan et al. Jul 2003 A1
20030175947 Liu et al. Sep 2003 A1
20040002131 Kim et al. Jan 2004 A1
20040029213 Callahan et al. Feb 2004 A1
20040029266 Barbera-Guillem Feb 2004 A1
20040053403 Jedrzejewski et al. Mar 2004 A1
20040058407 Miller et al. Mar 2004 A1
20040058408 Thomas et al. Mar 2004 A1
20040058437 Rodgers et al. Mar 2004 A1
20040067577 Wilson et al. Apr 2004 A1
20040072278 Chou et al. Apr 2004 A1
20040072363 Schembri Apr 2004 A1
20040077075 Jensen et al. Apr 2004 A1
20040121454 Jury et al. Jun 2004 A1
20040132166 Miller et al. Jul 2004 A1
20040197905 Hafeman Oct 2004 A1
20040224380 Chou et al. Nov 2004 A1
20040228771 Zhou et al. Nov 2004 A1
20040229349 Daridon Nov 2004 A1
20040229378 Schulte et al. Nov 2004 A1
20040234940 Van Der Steen et al. Nov 2004 A1
20040259237 Kellogg et al. Dec 2004 A1
20050014129 Cliffel et al. Jan 2005 A1
20050026134 Miller et al. Feb 2005 A1
20050026273 Zarur et al. Feb 2005 A1
20050032204 Rodgers et al. Feb 2005 A1
20050037471 Liu et al. Feb 2005 A1
20050047967 Chuang et al. Mar 2005 A1
20050089993 Boccazzi et al. Apr 2005 A1
20050106714 Zarur et al. May 2005 A1
20050255003 Summersgill et al. Nov 2005 A1
20050266582 Modlin et al. Dec 2005 A1
20050271560 Rodgers et al. Dec 2005 A1
20050277187 Johnson et al. Dec 2005 A1
20050287673 Johnson et al. Dec 2005 A1
20060019333 Rodgers et al. Jan 2006 A1
20060199260 Zhang et al. Sep 2006 A1
20060270023 LeDuc et al. Nov 2006 A1
Foreign Referenced Citations (45)
Number Date Country
19728520 Jan 1999 DE
1 221 617 Jul 2002 EP
1 226 871 Jul 2002 EP
62-079831 Apr 1987 JP
62079831 Apr 1987 JP
2000 005581 Jan 2000 JP
2001 129557 May 2001 JP
2001 157897 Jun 2001 JP
WO 9411489 May 1994 WO
WO 9917093 Apr 1999 WO
WO 9917093 Apr 1999 WO
WO 9934909 Jul 1999 WO
WO 9955827 Nov 1999 WO
WO 9957310 Nov 1999 WO
WO 0003805 Jan 2000 WO
WO 0017624 Mar 2000 WO
WO 0043552 Jul 2000 WO
WO 0056870 Sep 2000 WO
WO 0107891 Feb 2001 WO
WO 0138559 May 2001 WO
WO 0138559 May 2001 WO
WO 0192462 Jun 2001 WO
WO 0154813 Aug 2001 WO
WO 0168257 Sep 2001 WO
WO 0192870 Dec 2001 WO
WO 0211880 Feb 2002 WO
WO 0214539 Feb 2002 WO
WO 02057200 Jul 2002 WO
WO 02057200 Jul 2002 WO
WO 02083852 Oct 2002 WO
WO 02100542 Dec 2002 WO
WO 03035824 May 2003 WO
WO 03066876 Aug 2003 WO
WO 03093406 Nov 2003 WO
WO 03103813 Dec 2003 WO
WO 03104384 Dec 2003 WO
WO 2004009226 Jan 2004 WO
WO 2004016727 Feb 2004 WO
WO 2004016729 Feb 2004 WO
WO 2004069983 Aug 2004 WO
WO 2004076647 Sep 2004 WO
WO 2004112946 Dec 2004 WO
WO 2005120698 Dec 2005 WO
WO 2005121307 Dec 2005 WO
WO 2005121310 Dec 2005 WO
Provisional Applications (1)
Number Date Country
60188275 Mar 2000 US